Evidence map›Paper›PMID 33976386›Full record

ArticleMucosal immunology2021

Hyaluronic acid is a negative regulator of mucosal fibroblast-mediated enhancement of HIV infection.

Johanne H Egedal, Guorui Xie, Thomas A Packard, Anders Laustsen, Jason Neidleman, Konstantinos Georgiou, Satish K Pillai, Warner C Greene, Martin R Jakobsen, Nadia R Roan

Open access · hybridAbstract read
In one paragraph

Article in Mucosal immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Prospective bacterial and fungal sources of hyaluronic acid: A review.Computational and structural biotechnology journal · 2022
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Johanne H EgedalDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Guorui Xie *Gladstone Institute of Virology, Gladstone Institutes, San Francisco, CA, USA.
Thomas A Packard *Gladstone Institute of Virology, Gladstone Institutes, San Francisco, CA, USA.
Anders LaustsenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Jason NeidlemanGladstone Institute of Virology, Gladstone Institutes, San Francisco, CA, USA.
Konstantinos GeorgiouVitalant Research Institute, San Francisco, CA, USA.
Satish K PillaiVitalant Research Institute, San Francisco, CA, USA.
Warner C GreeneGladstone Institute of Virology, Gladstone Institutes, San Francisco, CA, USA.
Martin R JakobsenDepartment of Urology, University of California, San Francisco, CA, USA. mrj@biomed.au.dk.
Nadia R RoanGladstone Institute of Virology, Gladstone Institutes, San Francisco, CA, USA. nadia.roan@ucsf.edu.ORCID http://orcid.org/0000-0002-5464-1976
Gladstone Institutes · USUniversity of California, San Francisco · USAarhus University · DK

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 1988 to 2026
$93.6M
Phenotypic and mechanistic analysis of the in vivo HIV latent reservoir by single-cell technologiesR01AI147777 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROAN, NADIA R · 2019 to 2022
$3.8M
Elucidating the mechanism of progesterone-induced permissivity in the upperfemale reproductive tractR01AI127219 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROAN, NADIA R · 2016 to 2020
$2.1M
BD FACSAria II Flow CytometerS10RR028962 · NCRR · J. DAVID GLADSTONE INSTITUTES · PI CAVROIS, MARIELLE · 2011 to 2011
$544k
NCRR NIH HHS S10 RR028962NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI127219NIAID NIH HHS R01 AI147777
6 · The paper itself

Abstract

The majority of HIV infections are established through the genital or rectal mucosa. Fibroblasts are abundant in these tissues, and although not susceptible to infection, can potently enhance HIV infection of CD4+ T cells. Hyaluronic acid (HA) is a major component of the extracellular matrix of fibroblasts, and its levels are influenced by the inflammatory state of the tissue. Since inflammation is known to facilitate HIV sexual transmission, we investigated the role of HA in genital mucosal fibroblast-mediated enhancement of HIV infection. Depletion of HA by CRISPR-Cas9 in primary foreskin fibroblasts augmented the ability of the fibroblasts to increase HIV infection of CD4+ T cells. This amplified enhancement required direct contact between the fibroblasts and CD4+ T cells, and could be attributed to both increased rates of trans-infection and the increased ability of HA-deficient fibroblasts to push CD4+ T cells into a state of higher permissivity to infection. This HIV-permissive state was characterized by differential expression of genes associated with regulation of cell metabolism and death. Our results suggest that conditions resulting in diminished cell-surface HA on fibroblasts, such as genital inflammation, can promote HIV transmission by conditioning CD4+ T cells toward a state more vulnerable to infection by HIV.

Indexed as

BiomarkersCD4-Positive T-LymphocytesDisease SusceptibilityExtracellular MatrixFibroblastsGene Expression RegulationGene Knockdown TechniquesHIV-1HIV InfectionsHost-Pathogen InteractionsHumansHyaluronan SynthasesHyaluronic AcidMucous MembraneBiomarkersHAS2 protein, humanHyaluronan SynthasesHyaluronic Acid

Identifiers

PMID33976386
PMCPMC8379073
OpenAlexW3160885740

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.